re: big us rally in biotechs and drugs Just start to realize that the co now has Pfizer and Sanofi salesforces behind which are quite big. Also the co is treating at a nice profit only 0.5 % of possible eligible US patients and about 0.25 % of eligible patients worldwide so ther is big growth avenues ahead and expansion of P.E ratio
Add to My Watchlist
What is My Watchlist?